TABLE 2.
Parameter | G1 (n = 21) | G2 (n = 51) | G3 (n = 24) | Overall (n = 96) |
---|---|---|---|---|
uPAR PET–positive | 12 (57%) | 35 (69%) | 18 (75%) | 65 (68%) |
Data are number followed by percentage in parentheses. uPAR TLR was used to define lesions as uPAR-positive when lesion SUVmax–to–normal-liver SUVmean was ≥2. Of patients with G3, 8 of 9 NET G3 and 10 of 15 NEC were uPAR PET–positive.